| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |